Short telomeres are a risk factor for idiopathic pulmonary fibrosis
- PMID: 18753630
- PMCID: PMC2529100
- DOI: 10.1073/pnas.0804280105
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Abstract
Idiopathic interstitial pneumonias (IIPs) have a progressive and often fatal course, and their enigmatic etiology has complicated approaches to effective therapies. Idiopathic pulmonary fibrosis (IPF) is the most common of IIPs and shares with IIPs an increased incidence with age and unexplained scarring in the lung. Short telomeres limit tissue renewal capacity in the lung and germ-line mutations in telomerase components, hTERT and hTR, underlie inheritance in a subset of families with IPF. To examine the hypothesis that short telomeres contribute to disease risk in sporadic IIPs, we recruited patients who have no family history and examined telomere length in leukocytes and in alveolar cells. To screen for mutations, we sequenced hTERT and hTR. We also reviewed the cases for features of a telomere syndrome. IIP patients had shorter leukocyte telomeres than age-matched controls (P < 0.0001). In a subset (10%), IIP patients had telomere lengths below the first percentile for their age. Similar to familial cases with mutations, IPF patients had short telomeres in alveolar epithelial cells (P < 0.0001). Although telomerase mutations were rare, detected in 1 of 100 patients, we identified a cluster of individuals (3%) with IPF and cryptogenic liver cirrhosis, another feature of a telomere syndrome. Short telomeres are thus a signature in IIPs and likely play a role in their age-related onset. The clustering of cryptogenic liver cirrhosis with IPF suggests that the telomere shortening we identify has consequences and can contribute to what appears clinically as idiopathic progressive organ failure in the lung and the liver.
Conflict of interest statement
Conflict of interest statement: P.M.L. is a founding shareholder in Repeat Diagnostics, a company that specializes in length measurement of leukocyte telomeres with the use of flow FISH.
Figures
Similar articles
-
Telomerase mutations in families with idiopathic pulmonary fibrosis.N Engl J Med. 2007 Mar 29;356(13):1317-26. doi: 10.1056/NEJMoa066157. N Engl J Med. 2007. PMID: 17392301
-
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.PLoS One. 2010 May 19;5(5):e10680. doi: 10.1371/journal.pone.0010680. PLoS One. 2010. PMID: 20502709 Free PMC article.
-
Telomere shortening in familial and sporadic pulmonary fibrosis.Am J Respir Crit Care Med. 2008 Oct 1;178(7):729-37. doi: 10.1164/rccm.200804-550OC. Epub 2008 Jul 17. Am J Respir Crit Care Med. 2008. PMID: 18635888 Free PMC article.
-
Telomeres in Interstitial Lung Disease: The Short and the Long of It.Ann Am Thorac Soc. 2019 Feb;16(2):175-181. doi: 10.1513/AnnalsATS.201808-508CME. Ann Am Thorac Soc. 2019. PMID: 30540921 Free PMC article. Review.
-
Telomerase and idiopathic pulmonary fibrosis.Mutat Res. 2012 Feb 1;730(1-2):52-8. doi: 10.1016/j.mrfmmm.2011.10.013. Epub 2011 Nov 4. Mutat Res. 2012. PMID: 22079513 Free PMC article. Review.
Cited by
-
Telomere dysfunction causes alveolar stem cell failure.Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5099-104. doi: 10.1073/pnas.1504780112. Epub 2015 Apr 3. Proc Natl Acad Sci U S A. 2015. PMID: 25840590 Free PMC article.
-
Sequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associations.BMJ Open Respir Res. 2014 Dec 10;1(1):e000057. doi: 10.1136/bmjresp-2014-000057. eCollection 2014. BMJ Open Respir Res. 2014. PMID: 25553246 Free PMC article.
-
Genetic Underpinnings of Pulmonary Fibrosis: An Overview.Cardiovasc Hematol Agents Med Chem. 2024;22(3):367-374. doi: 10.2174/0118715257261006231207113809. Cardiovasc Hematol Agents Med Chem. 2024. PMID: 38284708 Review.
-
Epigenetics in lung fibrosis: from pathobiology to treatment perspective.Curr Opin Pulm Med. 2015 Sep;21(5):454-62. doi: 10.1097/MCP.0000000000000191. Curr Opin Pulm Med. 2015. PMID: 26176965 Free PMC article. Review.
-
Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF).BMC Pulm Med. 2019 Jul 18;19(1):130. doi: 10.1186/s12890-019-0895-6. BMC Pulm Med. 2019. PMID: 31319833 Free PMC article.
References
-
- American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277–304. - PubMed
-
- Loyd JE. Pulmonary fibrosis in families. Am J Respir cell Mol Biol. 2003;29:S47–S50. - PubMed
-
- Thomas AQ, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med. 2002;165:1322–1328. - PubMed
-
- Armanios MY, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med. 2007;356:1317–1326. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical